TREATMENT USE AND OVERALL SURVIVAL OF PATIENTS WITH UNRESECTABLE/METASTATIC MELANOMA IN COLOMBIA: A REAL WORLD STUDY

被引：0
|
作者：
Reyes, Sanchez J. M. [1 ]
Bolanos-Lopez, J. [2 ]
Bello, C. [2 ]
Rubio, A. C. [3 ]
Gonzalez, F. J. [2 ]
Toro, A. [2 ]
Chen, K. [4 ]
Arciniegas, J. [3 ]
Alarcon, B. A. [3 ]
Garcia, M. [1 ]
机构：
[1] Pfizer SAS, Bogota, Colombia
[2] Ctr Biociencias Sura, Medellin, Colombia
[3] Pfizer SAS, Bogota, Colombia
[4] Acaster Lloyd Consulting Ltd, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO146
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan
    Uhara, Hisashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (12) : 1508 - 1514
  • [42] Overall survival and treatment patterns among real-world patients with metastatic urothelial carcinoma treated with first-line therapy
    Simeone, Jason C.
    Nordstrom, Beth L.
    Patel, Ketan
    Klein, Alyssa B.
    Horne, Laura
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 102 - 102
  • [43] Trends over time in the proportion of sequential treatment and overall survival in patients with metastatic urothelial carcinoma in real-world practice.
    Yamamoto, Shoma
    Kato, Minoru
    Matsue, Taisuke
    Yukimatsu, Nao
    Takeyama, Yuji
    Otoshi, Taiyo
    Yamasaki, Takeshi
    Kuratsukuri, Katsuyuki
    Uchida, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 606 - 606
  • [44] Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide
    Alghazali, Mohammed
    Lofgren, Annica
    Cheng, Newton
    Fagerlund, Karin
    Bjartell, Anders
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (03) : 263 - 264
  • [45] Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real-World Study
    Foy, Patrick
    Higa, Sara
    Zhao, Jing
    Keapoletswe, Karabo
    Cirneanu, Lorena
    Venerus, Alessandra
    Raiteri, Louise
    Landfeldt, Erik
    Iob, Eleonora
    Lombard, Louise
    Li, Junlong
    Zagadailov, Erin
    EJHAEM, 2025, 6 (02):
  • [46] Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
    Asher, Nethanel
    Ben-Betzalel, Guy
    Lev-Ari, Shaked
    Shapira-Frommer, Ronnie
    Steinberg-Silman, Yael
    Gochman, Neta
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2020, 12 (08) : 1 - 18
  • [47] Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma
    Bedikian, Agop Y.
    Johnson, Marcella M.
    Warneke, Carla L.
    Papadopoulos, Nicholas E.
    Kim, Kevin
    Hwu, Wen-Jen
    Mclntyre, Susan
    Hwu, Patrick
    CANCER INVESTIGATION, 2008, 26 (06) : 624 - 633
  • [48] Survival in BRAF-mutant metastatic melanoma in the real-world setting: results from the Dutch Melanoma Treatment Registry
    Schouwenburg, M.
    Jochems, A.
    Aarts, M.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Franken, M.
    Groenewegen, G.
    de Groot, J-W.
    Haanen, J. B. A. G.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    Ten Tije, A. J.
    Vreugdenhil, G.
    Wouters, M.
    van der Hoeven, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] "REAL WORLD" PEMBROLIZUMAB IN METASTATIC MELANOMA
    Flynn, Alexandra E.
    Day, Fiona L.
    Geyde, Craig A.
    van der Westhuizen, Andre
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 122 - 122
  • [50] Treatment of patients with progressive unresectable metastatic melanoma with a heterologous polyvalent melanoma whole cell vaccine
    Vilella, R
    Benitez, D
    Milà, J
    Vilalta, A
    Rull, R
    Cuellar, F
    Conill, C
    Vidal-Sicart, S
    Costa, J
    Yachi, E
    Palou, J
    Malvehy, J
    Puig, S
    Marti, R
    Mellado, B
    Castel, T
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) : 626 - 631
12345